statistiche ricercatore

Continente	#
NA - Nord America	1.011
AS - Asia	980
EU - Europa	814
SA - Sud America	130
Continente sconosciuto - Info sul continente non disponibili	34
AF - Africa	19
OC - Oceania	1
Totale	2.989

Nazione	#
US - Stati Uniti d'America	973
IT - Italia	355
SG - Singapore	318
VN - Vietnam	186
CN - Cina	171
RU - Federazione Russa	125
HK - Hong Kong	107
BR - Brasile	87
DE - Germania	86
GB - Regno Unito	40
SE - Svezia	40
FR - Francia	36
BD - Bangladesh	35
KR - Corea	28
IE - Irlanda	27
IN - India	27
CA - Canada	21
PL - Polonia	19
AR - Argentina	17
ID - Indonesia	17
NL - Olanda	15
TR - Turchia	15
UA - Ucraina	14
ES - Italia	12
FI - Finlandia	12
IQ - Iraq	11
JP - Giappone	10
MX - Messico	8
ZA - Sudafrica	8
CO - Colombia	7
PH - Filippine	7
PK - Pakistan	7
SA - Arabia Saudita	7
AE - Emirati Arabi Uniti	5
CH - Svizzera	5
CR - Costa Rica	5
JO - Giordania	5
VE - Venezuela	5
AT - Austria	4
MY - Malesia	4
BO - Bolivia	3
CL - Cile	3
EC - Ecuador	3
HR - Croazia	3
IL - Israele	3
LT - Lituania	3
LV - Lettonia	3
MA - Marocco	3
NP - Nepal	3
PT - Portogallo	3
AL - Albania	2
BE - Belgio	2
ET - Etiopia	2
KE - Kenya	2
KG - Kirghizistan	2
PE - Perù	2
PS - Palestinian Territory	2
SK - Slovacchia (Repubblica Slovacca)	2
SY - Repubblica araba siriana	2
TH - Thailandia	2
AZ - Azerbaigian	1
BG - Bulgaria	1
BW - Botswana	1
CG - Congo	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
GE - Georgia	1
GR - Grecia	1
GY - Guiana	1
HT - Haiti	1
HU - Ungheria	1
JM - Giamaica	1
KZ - Kazakistan	1
LB - Libano	1
NG - Nigeria	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PY - Paraguay	1
QA - Qatar	1
SI - Slovenia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.955

Nome	#
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option	334
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin	320
Hyperuricemia in Cardiac Rehabilitation Patients: Prevalence and Association with Functional Improvement and Left Ventricular Ejection Fraction	275
Cardiac amyloidosis red flags: What all the cardiologist have to know	266
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality	263
Lipoproteina(a): associazione con la malattia aterosclerotica e valvolare e terapie emergenti	254
EFFECT OF ANTI-PCSK9 ANTIBODIES ON ARTERY STRUCTURE AND FUNCTION: THE NIGUARDA HOSPITAL COHORT	250
Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement	243
Resting Heart Rate and Arterial Stiffness: a Longitudinal Prospective Study in a Population of Hypertensive Patients	237
Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study	228
Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort	198
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study	121
Totale	2.989

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	8	0	0	1	0	0	1	1	0	1	1	1	2
2022/2023	224	3	13	24	22	27	29	11	23	14	14	19	25
2023/2024	213	6	6	14	13	30	43	23	10	7	6	11	44
2024/2025	782	25	42	41	62	52	42	38	32	52	137	65	194
2025/2026	1.532	165	89	121	209	171	81	225	65	120	138	50	98
2026/2027	135	44	63	28	0	0	0	0	0	0	0	0	0
Totale													2.989

Bicocca Open Archive